Simulations Plus Releases GastroPlus® X, The Next Generation PBPK/PBBM Modeling & Simulation Software
Director Daniel Weiner Sells 3,250 Shares of Simulations Plus Inc (SLP)
Director Daniel Weiner Sells 3,250 Shares of Simulations Plus Inc (SLP)
Insider Sale at Simulations Plus Inc (SLP): Director and 10% Owner Walter Woltosz Sells 20,000 ...
Insider Sale at Simulations Plus Inc (SLP): Director and 10% Owner Walter Woltosz Sells 20,000 Shares
Simulations Plus' (NASDAQ:SLP) Returns On Capital Not Reflecting Well On The Business
Simulations Plus' (NASDAQ:SLP) Returns On Capital Not Reflecting Well On The Business
Simulations Plus (NASDAQ:SLP): Promising Potential in Biotech Software
Simulations Plus (NASDAQ:SLP): Promising Potential in Biotech Software
Simulations Plus (SLP) DILIsym Software Licenses Renewed by FDA
Simulations Plus (SLP) DILIsym Software Licenses Renewed by FDA
Simulations Plus (SLP) DILIsym Software Licenses Renewed by FDA
Earnings Update: Simulations Plus, Inc. Beat Earnings And Now Analysts Have New Forecasts For This Year
Earnings Update: Simulations Plus, Inc. Beat Earnings And Now Analysts Have New Forecasts For This Year
Simulations Plus Second Quarter 2024 Earnings: Beats Expectations
Simulations Plus Second Quarter 2024 Earnings: Beats Expectations
Simulations Plus, Inc. (NASDAQ:SLP) Q2 2024 Earnings Call Transcript
Simulations Plus, Inc. (NASDAQ:SLP) Q2 2024 Earnings Call Transcript
U.S. FDA Renews DILIsym® Software Licenses for 7th Year
U.S. FDA Renews DILIsym® Software Licenses for 7th Year
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.